Hiccup

打嗝
  • 文章类型: Case Reports
    背景:打嗝是COVID-19感染的罕见并发症之一。有几篇发表的报道称,在急性COVID-19期间会出现持续的打嗝。然而,关于COVID-19急性发作后持续打嗝的报道很少。因此,大多数临床医生可能不知道这种罕见的表现.该病例突出了在急性COVID-19后期间表现出的持续性打嗝的非典型表现,临床医生需要注意。该病例增加了有关严重急性呼吸系统综合症冠状病毒2型(SARSCoV-2)感染相关症状和体征的知识。
    方法:一名27岁的男性黑人赞比亚患者因持续打嗝被送往我院急诊科,在COVID-19首次急性发作后35天。这与呼吸困难有关。没有其他症状。他没有肺部病史,胃肠,神经系统疾病或恶性肿瘤。他没有喝酒或抽烟。他从未使用过任何娱乐性药物。他被聘为首都一个主要的COVID中心的监测和评估官。在检查中,病人很焦虑。血压为141/82,脉搏率为每分钟95次,呼吸频率为每分钟26次呼吸,温度为36.8C,室内空气的氧饱和度为97%。全身检查正常。胸部X线和腹部超声检查正常。一种快速的COVID-19抗原检测,第二天进行的COVID-19聚合酶链反应(PCR)检测均为阴性。所有其他血液和生化检查,包括D-二聚体和C反应蛋白(CRP),也是正常的。诊断为急性后COVID-19相关的打嗝。患者对氯丙嗪25mg每8小时的治疗反应良好。第四剂氯丙嗪后,打嗝完全消失。
    结论:这是少数已发表的与COVID-19相关的持续性打嗝病例之一,发生在初次陈述后一个多月。大多数已发表的病例报告打嗝发生在急性COVID-19期间。因此,急性COVID-19后期间发生的打嗝可能与COVID-19无关。该病例强调了在持续性打嗝的鉴别诊断中需要考虑急性后COVID-19。
    BACKGROUND: Hiccups are among the rare complications of COVID-19 infections. There are several published reports of persistent hiccups presenting during the acute COVID-19 period. However, there are very few published reports of persistent hiccups occurring in the post-acute COVID-19 period. Consequently, most clinicians may not be aware of this rare presentation. This case highlights an atypical presentation of persistent hiccups that manifested during the post-acute COVID -19 period that clinicians need to be aware of. The caseadds to the ever increasing body of knowledge about symptoms and signs associated with Severe Acute Respiratory Syndrome Corona Virus type 2 (SARS CoV-2) infection.
    METHODS: A 27 year old male black Zambian patient presented to the emergency department of our hospital with persistent hiccup, 35 days after the initial acute episode of COVID-19. This was associated with breathlessness. There were no other symptoms. He had no history of pulmonary, gastrointestinal, neurological disease or malignancy. He did not take any alcohol or smoke. He had never used any recreational drugs. He was employed as a monitoring and evaluation officer at one of the main COVID centres in the capital. On examination, the patient was anxious. Blood pressure was 141/82, pulse rate was 95 beats per minute, respiratory rate was 26 breaths per minute, temperature was 36.8C and oxygen saturation was 97% on room air. Systemic examination was normal. Chest X-ray and abdominal ultrasonography were normal. A rapid COVID-19 antigen test, and COVID-19 Polymerase Chain Reaction (PCR) test that were done the following day were negative. All other haematological and biochemical tests, including D-dimer and C-reactive protein (CRP), were also normal. A diagnosis of post-acute COVID-19 associated hiccups was made. The patient responded well to treatment with chlorpromazine 25 mg 8 hourly. The hiccups disappeared completely after the fourth dose of chlorpromazine.
    CONCLUSIONS: This is one of the few published cases of COVID-19 associated persistent hiccups, occurring more than a month after the initial presentation. Most of the published cases report hiccups occurring in the acute COVID-19 period. Consequently, hiccups occurring in the post-acute COVID-19 period may not be attributable to COVID-19. This case has highlighted the need to consider post-acute COVID-19 in the differential diagnosis of persistent hiccup.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: English Abstract
    Chronic hiccups, lasting more than 48 hours, are a medical condition that remains challenging in both diagnosis and treatment. They can be the sole symptom of a serious underlying disorder, and should therefore not be overlooked, although gastroesophageal reflux disease (GERD) constitutes their most prevalent cause. Chronic hiccups mandate a comprehensive etiological assessment. Treatment strategy may include physical, pharmacological and interventional approaches, as described in literature, particularly when direct causal treatment is unattainable.
    Le hoquet chronique, de plus de 48 heures, est une entité dont la prise en charge est souvent méconnue. Il ne doit pas être négligé parce qu’il peut être le seul symptôme d’une maladie sous-jacente grave, même si le reflux gastro-œsophagien (RGO) en est la cause la plus fréquente. Face à un hoquet chronique, un bilan étiologique doit donc être effectué. Dans les cas où un traitement causal n’est pas envisageable, plusieurs possibilités de traitements physiques, médicamenteux et interventionnels sont décrites dans la littérature.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Systematic Review
    目的:本系统综述的目的是研究膈神经的膈下解剖结构。
    方法:对WebofScience数据库进行了计算机化的系统搜索。使用的关键术语是膈神经,子隔膜*,esophag*,肝脏,胃,pancre*,十二指肠*,intestin*,肠,gangli*,biliar*,奥迪,胆囊,Peritone*,脾,脾脾,hepat*,格里森,镰状,冠状韧带,肾,肾上,和肾上腺。还审查了“引用的”文章,以确保包括所有适当的研究。
    结果:共发现一千三百三十篇文章,其中18项符合纳入和排除标准。尸体研究质量评估量表显示,人体研究的方法学质量相当高,而实验室动物实验风险工具系统审查中心的修改版本表明动物研究的方法学质量较差。根据人类研究,已经证明了胃食管交界处的膈供应,胃,腹腔神经节,肝脏和它的冠状韧带,下腔静脉,胆囊和肾上腺,一半的人体样本显示膈神经与任何膈下结构的连接。
    结论:这篇综述提供了膈下神经供应和连接的第一个系统证据。这对于照顾患有颈部和肩部疼痛的人的专业人士来说是感兴趣的,以及周围膈肌疾病或打嗝的患者。然而,关于这种供应的自主神经或感官性质存在争议。
    OBJECTIVE: The aim of this systematic review is to study the subdiaphragmatic anatomy of the phrenic nerve.
    METHODS: A computerised systematic search of the Web of Science database was conducted. The key terms used were phrenic nerve, subdiaphragmat*, esophag*, liver, stomach, pancre*, duoden*, intestin*, bowel, gangli*, biliar*, Oddi, gallbladder, peritone*, spleen, splenic, hepat*, Glisson, falciform, coronary ligament, kidney, suprarenal, and adrenal. The \'cited-by\' articles were also reviewed to ensure that all appropriate studies were included.
    RESULTS: A total of one thousand three hundred and thirty articles were found, of which eighteen met the inclusion and exclusion criteria. The Quality Appraisal for Cadaveric Studies scale revealed substantial to excellent methodological quality of human studies, while a modified version of the Systematic Review Centre for Laboratory Animal Experimentation Risk of Bias Tool denoted poor methodological quality of animal studies. According to human studies, phrenic supply has been demonstrated for the gastro-esophageal junction, stomach, celiac ganglia, liver and its coronary ligament, inferior vena cava, gallbladder and adrenal glands, with half of the human samples studied presenting phrenic nerve connections with any subdiaphragmatic structure.
    CONCLUSIONS: This review provides the first systematic evidence of subdiaphragmatic phrenic nerve supply and connections. This is of interest to professionals who care for people suffering from neck and shoulder pain, as well as patients with peridiaphragmatic disorders or hiccups. However, there are controversies about the autonomic or sensory nature of this supply.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    鼻咽癌是一种罕见的癌症,但具有不同的种族和地理分布。患者由于靠近关键结构而出现一系列体征和症状,最好通过适形同步化学放射疗法进行治疗。我们介绍了一例45岁的男性被诊断为鼻咽癌,三个周期的新辅助化疗后,请我们接受放疗。根据现行的护理标准,患者计划通过体积电弧技术联合顺铂进行放疗。治疗的最初几天是平安无事的。治疗第四周后,患者出现持续性打嗝,保守药物治疗后仍未缓解.重新评估该计划,发现脑干的最大剂量为54.6Gy。怀疑放疗引起的水肿可能刺激迷走神经导致打嗝。患者开始注射类固醇和氯丙嗪。在保守治疗的五天内症状迅速恢复。
    UNASSIGNED: Nasopharyngeal carcinoma is an uncommon cancer but has a distinct racial and geographic distribution. Patient presents with constellation of signs and symptoms due to its vicinity to critical structures and are best treated by conformal concurrent chemo-radiotherapy. We present a case of 45-year-old male diagnosed with carcinoma nasopharynx, referred to us for radiotherapy after three cycles of neoadjuvant chemotherapy. As per the prevailing standard of care, patient was planned for radiotherapy by volumetric arc technique with concurrent cisplatin. Initial days of treatment were uneventful. After fourth week of treatment, patient developed persistent hiccup which was not relieved on conservative medications. Plan was re-evaluated and it revealed maximum dose of 54.6 Gy to the brainstem. Radiotherapy induced edema that could have stimulated vagus nerve leading to hiccups was suspected. Patient was started on injectable steroid and chlorpromazine. There was prompt recovery from the symptom within five days of conservative treatment.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    背景:打嗝是常见症状,持续时间少于48小时。然而,我们遇到一例长期打嗝的肾梗塞患者。打嗝与肾梗死的关系对鉴别长期打嗝患者有重要意义。
    方法:一名87岁的日本男性房颤患者接受抗血栓治疗,因长时间打嗝被送往急诊科。患者因皮质下出血停止房颤抗栓治疗,之后他经历了右背痛。根据计算机断层扫描图像,他被诊断为右肾梗塞,并继续进行抗血栓治疗.病人的打嗝停止了,他在医院第11天出院了.
    结论:打嗝可由各种临床状况引起。据推测,右肾梗塞的炎症刺激了该患者的隔膜并引起了长时间的打嗝;计算机断层扫描图像支持了这一理论。此病例报告显示,刺激隔膜的内脏器官疾病可引起打嗝,长期打嗝的患者应考虑肾脏疾病。
    BACKGROUND: Hiccups are common symptoms that last for less than 48 hours. However, we encountered a case of renal infarction in a patient with prolonged hiccup. The relationship between hiccups and renal infarction is important in differentiating patients with prolonged hiccups.
    METHODS: An 87-year-old Japanese man with atrial fibrillation and receiving antithrombotic therapy presented to the emergency department with prolonged hiccups. The patient discontinued antithrombotic therapy for atrial fibrillation due to subcortical bleeding, after which he experienced right back pain. He was diagnosed with right renal infarction based on computed tomography images, and the antithrombotic therapy was continued. The patient\'s hiccups ceased, and he was discharged on hospital day 11.
    CONCLUSIONS: Hiccups can be induced by various clinical conditions. It is hypothesized that the inflammation of the right kidney infarction stimulated the diaphragm and induced prolonged hiccups in this patient; this theory is supported by the computed tomography images. This case report shows that internal organ diseases irritating the diaphragm can cause hiccups, and renal disease should be considered in patients with prolonged hiccups.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    背景:持续超过48小时的打嗝很少见,有许多可能的原因需要进一步调查。
    方法:我们介绍了一名70多岁的男子,他在打嗝11天后入院。打嗝之前是腹痛,几个小时后自发消退。入院时,他在检查期间没有腹痛,但后来的CT扫描显示原因是穿孔性胆囊炎伴腹内脓肿。脓肿经皮引流并用抗生素治疗,打嗝停止了.
    结论:持续打嗝需要彻底检查,建议考虑头部和干的CT扫描,脑MRI扫描和上消化道内窥镜检查。治疗打嗝的根本原因是最终目标,同时对症治疗是优选的。
    Persistent hiccups lasting more than 48 hours are rare and have numerous possible causes that require further investigation.
    We present a man in his seventies who was admitted to hospital after 11 days of hiccups. The hiccups were preceded by abdominal pain that spontaneously receded after a few hours. At admission he had no abdominal pain during examination, but a CT scan later suggested that the cause was a perforated cholecystitis with an intra-abdominal abscess. The abscess was drained percutaneously and treated with antibiotics, and the hiccups stopped.
    Persistent hiccups warrant thorough examination, and it is recommended to consider CT scans of the head and truncus, cerebral MRI scan and an upper GI endoscopy. Treating the underlying cause of hiccups is the ultimate target, while symptomatic treatment simultaneously is preferred.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    简介:阿立哌唑,一种常用的抗精神病药,很少与打嗝的发作有关。这项研究旨在阐明患病率,危险因素,和阿立哌唑诱发的打嗝的管理。方法:我们报告了一例根据DSM-5标准诊断为躯体症状障碍的32岁男性的阿立哌唑诱发的打嗝病例。进行了全面的文献综述,29例阿立哌唑诱发的打嗝报告。患者人口统计学,剂量,打嗝的发作和持续时间,并对管理策略进行了分析。结果:阿立哌唑诱发的打嗝主要影响青少年和中年男性患者(86.7%)。大多数打嗝在处方后1-2天内发展(90.9%),并在阿立哌唑停药后1-4天内消退。停药阿立哌唑是最有效的管理策略(51.7%)。与苯二氮卓类药物共同给药被确定为重要的危险因素。讨论:研究结果表明,在阿立哌唑治疗的早期阶段,临床医生应警惕打嗝的发作。尤其是在男性患者和与苯二氮卓类药物共同给药的患者中。结论:临床医生在阿立哌唑治疗早期应警惕打嗝。考虑人格和心理因素对于管理精神病患者的打嗝至关重要。
    Introduction: Aripiprazole, a commonly prescribed antipsychotic, has been rarely associated with the onset of hiccups. This study aims to elucidate the prevalence, risk factors, and management of aripiprazole-induced hiccups. Methods: We report a case of aripiprazole-induced hiccups in a 32-year-old male diagnosed with Somatic Symptom Disorder per DSM-5 criteria.A comprehensive literature review was conducted, identifying 29 case reports of aripiprazole-induced hiccups. Patient demographics, dosage, onset and duration of hiccups, and management strategies were analyzed. Results: Aripiprazole-induced hiccups predominantly affected adolescents and middle-aged male patients (86.7%). The majority of hiccups developed within 1-2 days post-prescription (90.9%) and resolved within 1-4 days after discontinuation of aripiprazole. Discontinuation of aripiprazole was the most effective management strategy (51.7%). Co-administration with benzodiazepines was identified as a significant risk factor. Discussion: The findings suggest that clinicians should be vigilant for the onset of hiccups during the early stages of aripiprazole treatment, especially in male patients and those co-administered with benzodiazepines. Conclusion: Clinicians should be vigilant for hiccups during early aripiprazole treatment. Considering personality and psychological factors is crucial in managing hiccups in psychiatric patients.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号